Atz-L5
Atz-L5 is a PD-L1 PTAC (PSMA-targeted chimera) degrader (DC50: 18 pM in PC3-PIP cells; 2 pM in LNCaP cells) and LYTAC. Atz-L5 promotes lysosomal degradation of PD-L1 in PSMA-positive prostate cancer cells. Atz-L5 is applicable to the research of prostate cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C82H119N13O32
- 分子量:1798.89
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
DC50: PD-L1, 18 pM in PC3-PIP cells; 2 pM in LNCaP cells[1]
Atz-L5 (0.01-100 nM; 24 h) potently degrades PD-L1 in PC3-PIP prostate cancer cells with a DC50 of 18 pM and 70% maximum degradation after 24 h of treatment[1].
Atz-L5 (0.01-10 nM; 24 h) potently degrades PD-L1 in LNCaP prostate cancer cells with a DC50 of 2 pM and 81% maximum degradation after 24 h of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
分子量 1798.89
-
分子式 C82H119N13O32
-
SMILES
O=C(N(CC1=C2C=CC=C1)C(C=CC=C3)=C3C4=C2N=NN4CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(N)=O)CCC(NCCCC[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC([C@@H](NC(CC5=CC=C(CNC(NCCCC[C@@H](C(O)=O)NC(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)C=C5)=O)CC(O)=O)=O)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Atz-L5 関連分類
HY-181830 関連分類
Powered by Bioz